Dr. Anna Wald is our Principal Investigator for anti-HSV mAb UB-621’s phase II clinical trial in U.S. Dr. Wald is a board certified physician in both Internal Medicine and Infectious Disease and the director of the University of Washington (UW)’s Virology Research Clinic at Harborview. She is also a professor of Medicine, Epidemiology and Laboratory Medicine at University of Washington. She is a fellow of American College of Physician and Infectious Diseases Society of America. Her clinical and research interests include infectious diseases, clinical virology, sexually transmitted infections, and infection in immunocompromised persons, epidemiology and vaccines for herpes virus infections.
Dr. Wald received her M.D. from Icahn School of Medicine at Mount Sinai Medical School and has been in practice for more than 20 years.